7176 - 7200 of 7916 Results
Title
Year
-
OPENTitle: Longitudinal assessment of tau and amyloid beta in cerebrospinal fluid of Parkinson diseaseJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 126Issue #: 5Start Page: 671End Page: 682Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-013-1121-xBest OA location URL: https://europepmc.org/articles/pmc3796193?pdf=renderCitation Count: 77
-
RESTRICTEDTitle: Aberrant Protein S-Nitrosylation in Neurodegenerative DiseasesJournal Name: NeuronPublisher: Elsevier BVVol: 78Issue #: 4Start Page: 596End Page: 614Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neuron.2013.05.005Best OA location URL: http://www.cell.com/article/S089662731300398X/pdfCitation Count: 305
- Synthesis of the Alzheimer Drug Posiphen into its Primary Metabolic Products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their Inhibition of Amyloid Precursor Protein, α -Synuclein Synthesis, Interleukin-1β Release, and Cholinergic Action.2013OPENTitle: Synthesis of the Alzheimer Drug Posiphen into its Primary Metabolic Products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their Inhibition of Amyloid Precursor Protein, α -Synuclein Synthesis, Interleukin-1β Release, and Cholinergic Action.Journal Name: Anti-Inflammatory & Anti-Allergy Agents in Medicinal ChemistryPublisher: Bentham Science Publishers Ltd.Vol: 12Issue #: 2Start Page: 117End Page: 128Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2174/1871523011312020003Best OA location URL: https://europepmc.org/articles/pmc5214460?pdf=renderCitation Count: 25
- Understanding the neurobiology of CD200 and the CD200 receptor: a therapeutic target for controlling inflammation in human brains?2013OPENTitle: Understanding the neurobiology of CD200 and the CD200 receptor: a therapeutic target for controlling inflammation in human brains?Journal Name: Future NeurologyPublisher: Informa UK LimitedVol: 8Issue #: 3Start Page: 321End Page: 332Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2217/fnl.13.14Best OA location URL: https://europepmc.org/articles/pmc3815586?pdf=renderCitation Count: 47
-
OPENTitle: Short- and Long-Term Effects of LRRK2 on Axon and Dendrite GrowthJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 8Issue #: 4Start Page: e61986End Page: e61986Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0061986Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0061986&type=printableCitation Count: 47
- Neuroimmunological Processes in Parkinson's Disease and their Relation to α-Synuclein: Microglia as the Referee between Neuronal Processes and Peripheral Immunity2013RESTRICTEDTitle: Neuroimmunological Processes in Parkinson's Disease and their Relation to α-Synuclein: Microglia as the Referee between Neuronal Processes and Peripheral ImmunityJournal Name: ASN NeuroPublisher: Informa UK LimitedVol: 5Issue #: 2Start Page: AN20120066End Page: AN20120066Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1042/an20120066Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1042/AN20120066Citation Count: 202
- Permeabilization of the Blood-Brain Barrier via Mucosal Engrafting: Implications for Drug Delivery to the Brain2013OPENTitle: Permeabilization of the Blood-Brain Barrier via Mucosal Engrafting: Implications for Drug Delivery to the BrainJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 8Issue #: 4Start Page: e61694End Page: e61694Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0061694Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0061694&type=printableCitation Count: 36
- Correlation of Inner Retinal Thickness Evaluated by Spectral-Domain Optical Coherence Tomography and Contrast Sensitivity in Parkinson disease2013OPENTitle: Correlation of Inner Retinal Thickness Evaluated by Spectral-Domain Optical Coherence Tomography and Contrast Sensitivity in Parkinson diseaseJournal Name: Journal of Neuro-OphthalmologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 33Issue #: 2Start Page: 137End Page: 142Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/wno.0b013e31828c4e1aBest OA location URL: https://journals.lww.com/jneuro-ophthalmology/fulltext/2013/06000/correlation_of_inner_retinal_thickness_evaluated.9.aspxCitation Count: 77
- Concurrent regulation of the transcription factors Nrf2 and ATF4 mediates the enhancement of glutathione levels by the flavonoid fisetin2013RESTRICTEDTitle: Concurrent regulation of the transcription factors Nrf2 and ATF4 mediates the enhancement of glutathione levels by the flavonoid fisetinJournal Name: Biochemical PharmacologyPublisher: Elsevier BVVol: 85Issue #: 12Start Page: 1816End Page: 1826Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bcp.2013.04.010Citation Count: 75
- TDP-43 deposition in prospectively followed, cognitively normal elderly individuals: correlation with argyrophilic grains but not other concomitant pathologies2013OPENTitle: TDP-43 deposition in prospectively followed, cognitively normal elderly individuals: correlation with argyrophilic grains but not other concomitant pathologiesJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 126Issue #: 1Start Page: 51End Page: 57Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-013-1110-0Best OA location URL: https://europepmc.org/articles/pmc3691299?pdf=renderCitation Count: 85
- Bee Venom and Its Component Apamin as Neuroprotective Agents in a Parkinson Disease Mouse Model2013OPENTitle: Bee Venom and Its Component Apamin as Neuroprotective Agents in a Parkinson Disease Mouse ModelJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 8Issue #: 4Start Page: e61700End Page: e61700Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0061700Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0061700&type=printableCitation Count: 112
- α4β2 nicotinic receptors play a role in the nAChR-mediated decline in l-dopa-induced dyskinesias in parkinsonian rats2013OPENTitle: α4β2 nicotinic receptors play a role in the nAChR-mediated decline in l-dopa-induced dyskinesias in parkinsonian ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 71Issue #:Start Page: 191End Page: 203Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2013.03.038Best OA location URL: https://europepmc.org/articles/pmc3685407?pdf=renderCitation Count: 42
-
RESTRICTEDTitle: α‐Synuclein: The Long Distance RunnerJournal Name: Brain PathologyPublisher: WileyVol: 23Issue #: 3Start Page: 350End Page: 357Publication Date:Open Access(OA) Status: RESTRICTEDLicense: unspecified-oaDOI - Digital Object Identifier: 10.1111/bpa.12046Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bpa.12046Citation Count: 102
-
RESTRICTEDTitle: Lysosomal impairment in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 6Start Page: 725End Page: 732Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25462Best OA location URL: https://europepmc.org/articles/pmc5131721?pdf=renderCitation Count: 267
-
OPENTitle: Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patientsJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 80Issue #: 18Start Page: 1698End Page: 1701Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182904faaBest OA location URL: https://europepmc.org/articles/pmc3716474?pdf=renderCitation Count: 185
- Comprehensive characterization and optimization of anti-LRRK2 (leucine-rich repeat kinase 2) monoclonal antibodies2013OPENTitle: Comprehensive characterization and optimization of anti-LRRK2 (leucine-rich repeat kinase 2) monoclonal antibodiesJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 453Issue #: 1Start Page: 101End Page: 113Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1042/bj20121742Best OA location URL: https://portlandpress.com/biochemj/article-pdf/453/1/101/675176/bj4530101.pdfCitation Count: 90
- Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer's disease2013OPENTitle: Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 34Issue #: 8Start Page: 2077.e11End Page: 2077.e18Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2013.02.016Best OA location URL: https://europepmc.org/articles/pmc3830921?pdf=renderCitation Count: 134
-
OPENTitle: Parkinson's disease cognitive network correlates with caudate dopamineJournal Name: NeuroImagePublisher: Elsevier BVVol: 78Issue #:Start Page: 204End Page: 209Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2013.03.070Best OA location URL: https://europepmc.org/articles/pmc3672243?pdf=renderCitation Count: 89
- Improvement of freezing of gait with amantadine in a patient with oculopharyngeal muscular dystrophy and parkinsonism2013RESTRICTEDTitle: Improvement of freezing of gait with amantadine in a patient with oculopharyngeal muscular dystrophy and parkinsonismJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 19Issue #: 6Start Page: 643End Page: 644Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2013.02.016Citation Count: 0
-
OPENTitle: BACE1 Levels by APOE Genotype in Non-Demented and Alzheimer’s Post-Mortem BrainsJournal Name: Current Alzheimer ResearchPublisher: Bentham Science Publishers Ltd.Vol: 10Issue #: 3Start Page: 309End Page: 315Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2174/1567205011310030010Best OA location URL: https://europepmc.org/articles/pmc4104947?pdf=renderCitation Count: 12
- Endogenous LRRK2 dimerizes and translocates to novel membrane compartments during monocyte activation2013RESTRICTEDTitle: Endogenous LRRK2 dimerizes and translocates to novel membrane compartments during monocyte activationJournal Name: The FASEB JournalPublisher: WileyVol: 27Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1096/fasebj.27.1_supplement.873.17Citation Count: 1
-
OPENTitle: Gender differences in cholinergic and dopaminergic deficits in Parkinson diseaseJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 120Issue #: 10Start Page: 1421End Page: 1424Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00702-013-1013-1Best OA location URL: https://europepmc.org/articles/pmc3762897?pdf=renderCitation Count: 15
- Identification of extracellular miRNA in human cerebrospinal fluid by next-generation sequencing2013OPENTitle: Identification of extracellular miRNA in human cerebrospinal fluid by next-generation sequencingJournal Name: RNAPublisher: Cold Spring Harbor LaboratoryVol: 19Issue #: 5Start Page: 712End Page: 722Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1261/rna.036863.112Best OA location URL: http://rnajournal.cshlp.org/content/19/5/712.full.pdfCitation Count: 184
- Bapineuzumab Alters Aβ Composition: Implications for the Amyloid Cascade Hypothesis and Anti-Amyloid Immunotherapy2013OPENTitle: Bapineuzumab Alters Aβ Composition: Implications for the Amyloid Cascade Hypothesis and Anti-Amyloid ImmunotherapyJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 8Issue #: 3Start Page: e59735End Page: e59735Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0059735Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0059735&type=printableCitation Count: 33
-
OPENTitle: Measuring mild cognitive impairment in patients with Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 5Start Page: 626End Page: 633Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25426Best OA location URL: https://europepmc.org/articles/pmc4524474?pdf=renderCitation Count: 132